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Recognition and application of blood group differences on human red cells permitted the
development of safe procedures for blood transfusion. Blood group antigens are markers on
surface-exposed red cell proteins or the sugar moiety ofglycoproteins or glycolipids. Apart from
their presumed biological function, some antigens have been identified as receptors for host/
parasite interactions. Thus, carbohydrates that determine P antigenicity are the binding receptor
for certain strains ofpyelonephritic coliforms. Other pathogenic coliforms bind to the membrane
structure that carries the Dr' antigen. A structure associated with Duffy antigens is the
attachment receptor for the parasite of Plasmodium vivax malaria, while Plasmodium falci-
parum parasites bind to structures associated with membraneglycophorins.
Structure/function relationships have been established by thefinding that lackofRhprotein in
red cells of Rhnu,, phenotype is associated with stomatocytic cell morphology and a hemolytic
state. Absence of glycophorin C, and the Gerbich blood group antigens that it carries, is
associated with elliptocytic red cells. Absence of Kx antigen protein in the Kell system is
associated with the McLeod blood group phenotype, with acanthocytic cell morphology and
reduced in vivo survival. McLeod individuals also have late-onset muscular dystrophy and
neurological disorders.
Discovery ofblood group polymorphisms on human red cells was the major event in
the development ofsafe procedures for clinical transfusion practice. Starting with the
ABO system, about 20 independent blood group systems have been recognized, many
ofthem with extensive intra-group antigenic complexity [1]. Byvirtueoftheir relative
ease of serological detection and their generally straightforward inheritance, blood
group studies have been widely utilized in anthropological, genetic, and forensic
investigations. In clinical situations, they have been used to monitor in vivo survival of
transfused red cells. More recently, they have been used as tools to probe the structure
of the red cell membrane. Persistence of blood group genes in evolution suggests that
blood groupantigens label structuresofbiological importance. Onlyrecently, however,
have associations between the presence ofsome red cell antigens and red cell function
been recognized.
Nearly 600discrete antigens have been identified [1]. Whilemanyofthemrepresent
sub-specificities within major blood group systems, others appear to be individual and
independent markers. It is probable that all important antigens, from the clinical
viewpoint, have now been discovered.
Almost all blood group antigens are inherited characteristics. The only exceptions
are the rare acquired A and acquired B antigens and perhaps certain cryptantigens
involved in polyagglutination phenomena. Even cryptantigens must be under genetic
control, however, forthey areconcealed belowthesurfaceofall red cells. In mostcases,
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exposure of a cryptantigen by a microbial enzyme converts a latent into an active
receptor, which then reacts with an antibody present in all normal human sera.
THE NATURE OF ANTIGENS
A vast literature exists on the serology and formal genetics of the human red cell
blood groups. Many of the blood group gene loci have been assigned to specific
chromosomes, where they provide important markers. The Xg and Xk systems are
X-linked, but all other systems are autosomal. Chromosome 1 carries genes for the Rh,
Duffy, Scianna, and Radin systems and is the leader in blood group genetic assign-
ments. Information is growing concerning the biochemical nature of some of the
antigenic determinants and the membrane structures that carry them, but relatively
little is known ofbiological functions for these cell-surface-exposed structures.
Understanding of a blood group requires knowledge of its phenotypic complexity
and the genetic background from which it arises, the biochemical nature ofits antigens
and the membrane structure that carries them, and its function in cellular biology.
Recognition of a blood group begins with discovery of an antibody. Such an antibody
may follow immunization by blood transfusion or pregnancy, and it is thus the blood
group serologist who recognizes variation and poses questions that biochemists and cell
biologists will subsequently address.
Blood group antigenicity may be a characteristic ofa cell-surface-exposed protein or
the sugar moiety ofa glycoprotein or glycolipid. There is a general correlation between
the nature of an antigen and its biological importance. Antigens in which an immu-
nodominant sugar determines specificity, (e.g., A, B, H, Lea, Sda, and so on) do not
appear to be vital for normal cell function and survival. Absence of the sugar does not
compromise the cell. Conversely, when antigenicity depends upon the nature of a
membrane protein, absence of the protein may affect the cell shape and its proper in
vivo survival. Thus, some null blood types in which a red cell blood group protein is
missing are characterized by abnormal cell morphology and a permanent hemolytic
state, but null phenotype cells that have missing carbohydrates are normal.
While early studies suggested that most blood group antigens were restricted to
erythropoietic tissues, recent reports have described a wider tissue distribution of some
of the structures that carry these antigenic markers. Some red cell antigens are also
present in solution in plasma and otherbodyfluids (e.g. Lewis, Sda, Cha). In most cases,
antibodies to these antigens do not cause hemolysis of transfused incompatible red
cells, as the antibodies are inhibited by the free plasma antigen. The ability of any
blood group antibody to cause hemolytic disease in a newborn infant depends upon
whether the reactive antigen is welldeveloped on fetal redcells, whether theantibody is
an IgG placenta-passing protein, and whether it has the potential to induce in vivo red
cell destruction.
BLOOD GROUP ANTIGENS AS BIOLOGICAL RECEPTORS
An important recent development has been recognition of blood group structures as
receptors for cell attachment and infection by certain organisms and parasites. Thus,
some strains of pathogenic E. coli bind to specific structures that are part of P blood
group glycosphingolipids on epithelial cells and also on red cells [2]. Binding is
important in the initiation of these urinary tract infections and is directly related to
bacterial virulence. These strains ofpathogenic coliform cannot interact with cells that
lack P antigen, the rare p type cells. Filamentous recognition structures on the
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coliforms, called pili or fimbriae, interact with a specific disaccharide (galactosyl-
galactose) of the P antigen. Binding of pyelonephritic E. coli to cells carrying the P
antigen is inhibited by a synthetic disaccharide with a structure the same as that of P
antigen carbohydrates.
A high-incidence antigen named Dra appears to be a binding receptor for some other
strains ofpathogeniccoliform [3]. The Dra antigen haswidedistribution ontissuecells,
and the capability of these organisms to induce agglutination of Dr(a+) red cells but
not ofDr(a-) cells probably reflects a cell-to-cell interaction ofbiological significance
[4]. Further interest has been caused by the finding that Dra is one of a series of
high-incidence red cell antigens that arecollectively called "Cromer-related." Cells of
a rare type called INAB lack all of the antigens of this complex [5]. It has been
reported that a 70,000 dalton red cell membrane sialoglycoprotein, which carries these
antigens, is identical to the decay accelerating factor (DAF) glycoprotein, which is a
complement regulatory factor present on many cell types as a surfaceglycoprotein and
also in solution in plasma and other body fluids.
AnWj is the name given to a high-frequency independent antigen, first identified on
red cells. The antigen has a wider tissue distribution and has been shown to be a
binding receptor on epithelial cells and red cells forHaemophilus influenzae [6]. Cells
lacking the antigen do not interact with theorganism.
Someofthe most important receptors forhost/parasite interactions involve malaria.
Seminal workby Millerand hiscolleagues firstdemonstrated that a red cell membrane
structure related to the Duffyblood group is a receptorfor attachmentofthe merozoite
of Plasmodium knowlesi malaria, a simian parasite that can infect man [7]. By
elegant in vitro experiments, they demonstrated that malaria merozoites would not
attach to, or invade, red cells lacking the major Duffy antigens Fya and Fyb [i.e., the
phenotype Fy(a-b-)]. Further studies established that Plasmodium vivax, the
parasite causing one type of human malaria, utilizes the same red cell receptor;
individuals of Fy(a-b) type are resistant to this type of malaria [8]. The Fy(a-b-)
type is very rare among Caucasians but has a frequencyofabout 78 percent in African
Negroes. The latter finding is presumed to reflect a long period of selective pressure,
conferring an advantageon individualsofFy(a-b-) type in theAfrican environment.
P.falciparum, the causative parasite of malignant malaria, does not utilize the same
receptor for its attachment to red cells [8]. There is evidence that the recognition
structure for this parasite is present on the major red cell membrane sialoglycoproteins
(glycophorins) [9]. Interaction between P.falciparum and red cells does not appear to
be a charge-related phenomenon but probably depends on spatial conformation of
clusters ofoligosaccharides close to the cell membrane forming a specific receptor.
STRUCTURE/FUNCTION RELATIONSHIPS
Rhnull
Red cells of the rare Rhn.11 type lack Rh polypeptide and all of the blood group
antigens that are products of the Rh gene, which is located on the short arm of
chromosome 1. Individuals of Rhnull type have stomatocytic red cell morphology and
shortened in vivo red cell survival [10]. The hematological defect is probably a
consequence of a cell membrane abnormality caused by lack of Rh protein. The cells
have altered membrane permeability in which passive and active transport ofNa+ and
K+ are increased [11]. It does not appear, however, that Rh and the Na+K+ pump
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share common structures on the red cell membrane. Rhn.11 red cells have more Na+K+
pumps than normal cells, possibly a compensatory mechanism for the K+ leak [12].
LEACH PHENOTYPE
Gerbich (Ge) is a public antigen of almost universal distribution in Caucasian
populations. Rare individuals are encountered who are Ge-negative; however, up to 50
percent of the population in some areas ofPapua, New Guinea, are Ge-negative [13].
Serum from a Ge-negative person may contain anti-Ge antibody, which creates a
major logistic problem in providing compatible blood for transfusion [14].
A particularly interesting variant of the Ge-negative phenotype is called the Leach
phenotype. These cells lack the sialoglycoproteins that are collectively called glyco-
phorin C and exhibit an elliptocytic red cell shape with reduced in vivo survival. The
missing sialoglycoproteins, which carry the Gerbich antigenic marker, appear to be
important in the organization and function ofthe red cell membrane [15].
THE KELL BLOOD GROUP AND McLEOD SYNDROME
Kell is one of the major blood group systems of human red cells. Since discovery of
the first antibody in 1946, the system has grown steadily in its recognized complexity
and presently includes 24 antigens [16]. It is a clinically important system with strong
immunogenicity, and active Kell group incompatibility has caused many hemolytic
reactions to blood transfusion and numerous cases of severe hemolytic disease in
newborn infants.
Among the variant phenotypes in the Kell system, McLeod is one of considerable
interest [17]. The McLeod type of red cells react weakly with Kell system antibodies
and lack an otherwise ubiquitous antigen named Kx. While Kell phenotypes are
inherited as autosomal co-dominant characteristics, inheritance of Kx is through an
X-borne gene, named Xk [16]. All examples of the McLeod type recognized thus far
(>60) have been from males, and transmission occurs via a carrier female.
The striking feature of the McLeod blood type has been the clinical syndrome that
accompanies it. Abnormalities in these individuals involve erythropoietic, neurologic,
and muscular tissue [16]. The red cells have a membrane defect manifested by
acanthocytic morphology, changes in the biochemical characteristics of several mem-
branecomponents, and reduced in vivosurvival. McLeod subjects show the hematolog-
ical and biochemical changes expected ofa compensated hemolytic state [18]. Muscle
changes are manifested by late-onset (usually >40 years) skeletal muscle wasting,
cardiomegaly, and sometimes cardiomyopathy, and elevated levels of serum creatine
kinase and carbonic anhydrase. Muscle biopsy has shown changes consistent with a
neurogenic myopathy [19]. Neurological changes present as areflexia and slowly
progress to choreiform and dystonic movements of some severity. In addition to these
changes, there is an association between X-linked chronic granulomatous disease and
McLeod syndrome. Some boys with X-linked chronic granulomatosus disease also
have the McLeod red cell type. Thechronicgranulomatosus disease and Xk (McLeod)
loci are close together on the X chromosome at Xp21 [20]. In some boys, an
X-chromosome deletion spanning both loci has been demonstrated as the cause of the
associated condition.
Kell antigens arecarried on a 93,000 dalton red cell membrane glycoprotein, but the
gene locus has not yet been mapped [21]. Kx antigen is a marker on a 37,000 dalton
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membrane protein, encoded by the Xk gene on the X chromosome [22]. Cellular
abnormalities correlate with absence ofKx antigen protein.
McLEOD CARRIERS
With recognition that males having the McLeod red cell type develop a significant
pathophysiological condition has come a need for accurate identification of female
carriers of the gene. The McLeod locus is inactivated by the Lyon phenomenon of
X-chromosome inactivation [18]. Somatic cells from female carriers have only one X
chromosome expressed, and thus only one functional Xk gene. The phenotypic result is
cellular mosaicism in the peripheral blood. One red cell population consists of normal
discocytes of common Kell blood group. A second cell population, which derives from
an erythropoietic clone in which the mutant Xk gene is expressed, consists of the
McLeod type of acanthocytes. Flow cytometric analysis is a sensitive means of
demonstrating cellular mosaicism in femalecarriersofthe McLeod gene. Studies using
Kell antibodies by flow cytometry on red cells from carriers reveal the double red cell
population with high sensitivity [16].
CONCLUSION
The demands of clinical transfusion practice gave early impetus to blood group
studies. Use of blood group antibodies as probes to reveal the structure of the red cell
membrane and as markers on receptors involved in host/parasite interactions are
important new developments.
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